Vistin Pharma ASA (OSL:VISTN)
Norway flag Norway · Delayed Price · Currency is NOK
24.30
-0.20 (-0.82%)
At close: Jun 5, 2025

Vistin Pharma ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1,1441,0511,033701859774
Upgrade
Market Cap Growth
9.42%1.72%47.47%-18.47%11.06%67.79%
Upgrade
Enterprise Value
1,1331,0531,034739809678
Upgrade
Last Close Price
24.5523.7021.6614.6918.0115.88
Upgrade
PE Ratio
14.9016.7522.66-34.56-
Upgrade
Forward PE
-9.459.459.459.459.45
Upgrade
PS Ratio
2.602.452.362.303.083.05
Upgrade
PB Ratio
3.453.403.202.563.122.84
Upgrade
P/TBV Ratio
3.453.403.202.563.122.84
Upgrade
P/FCF Ratio
14.3715.6714.21---
Upgrade
P/OCF Ratio
11.149.7411.41-62.82-
Upgrade
PEG Ratio
-1.721.721.721.721.72
Upgrade
EV/Sales Ratio
2.572.452.362.432.902.67
Upgrade
EV/EBITDA Ratio
9.9310.2012.19138.7118.9112.49
Upgrade
EV/EBIT Ratio
11.9512.3515.08-24.3414.89
Upgrade
EV/FCF Ratio
14.2315.7114.23---
Upgrade
Debt / Equity Ratio
0.010.00-0.180.01-
Upgrade
Debt / EBITDA Ratio
0.020.01-7.950.03-
Upgrade
Debt / FCF Ratio
0.030.02----
Upgrade
Asset Turnover
1.091.091.080.820.850.62
Upgrade
Inventory Turnover
1.991.912.162.192.572.62
Upgrade
Quick Ratio
1.471.011.240.621.923.38
Upgrade
Current Ratio
2.692.242.431.353.364.39
Upgrade
Return on Equity (ROE)
24.44%19.85%15.29%-1.72%9.07%-28.27%
Upgrade
Return on Assets (ROA)
14.61%13.53%10.58%-1.03%6.35%6.89%
Upgrade
Return on Capital (ROIC)
17.86%16.83%13.29%-1.27%7.56%8.27%
Upgrade
Return on Capital Employed (ROCE)
27.20%26.60%20.50%-11.40%15.70%
Upgrade
Earnings Yield
6.71%5.97%4.41%-0.67%2.89%-12.53%
Upgrade
FCF Yield
6.96%6.38%7.03%-10.68%-2.13%-25.70%
Upgrade
Dividend Yield
4.84%5.27%4.62%5.11%4.16%3.15%
Upgrade
Payout Ratio
57.73%123.65%--89.17%-
Upgrade
Total Shareholder Return
4.75%5.27%4.62%5.11%4.16%3.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.